国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
莫西沙星与左氧氟沙星治疗下呼吸道感染比较
Comparative Study of Efficacy of Moxifloxaction and Levofloxaction in the Treatment of the Lower Respiratory Tract Infection
投稿时间:2007-03-13  修订日期:2007-03-27
DOI:
中文关键词:  莫西沙星  下呼吸道感染  左氧氟沙星
英文关键词:Moxifloxaction,Lower respiratory tract inflection,Levofloxaction
基金项目:
徐西琳  余爱荣
广州军区武汉总医院呼吸内科,广州军区武汉总医院临床药理科 武汉430070
摘要点击次数: 1536
全文下载次数: 109
中文摘要:
      目的:评价莫西沙星注射剂治疗下呼吸道感染的疗效及安全性。方法:将64例社区获得性肺炎(CAP)及慢性支气管炎急性发作(AECB)患者,随机分为治疗组和对照组各32例,治疗组予以莫西沙星400 mg,ivd qd;对照组给予左氧氟沙星200 mg,ivd bid,疗程均为7~14 d。结果:莫西沙星治疗组临床有效率(93.6%)虽然高于左氧氟沙星对照组(78.1%),但两组比较差异不显著,而治疗组的痊愈率(71.8%)显著高于对照组(46.9%),P<0.05;在临床症状、体征、实验室检查恢复正常方面,莫西沙星治疗组均较对照组显著减少;在细菌清除方面,尽管与左氧氟沙星比较差异不显著,但仍高于左氧氟沙星。结论:莫西沙星注射剂治疗下呼吸道感染的疗效确切,安全性好。
英文摘要:
      Objective:To evaluate the efficacy and safety of moxifloxaction and levofloxaction in the treatment of the lower respiratory tract inflection.Method:64 cases patients were randomly divided into two groups.The clinical trial group was treated with moxifloxaction 400mg once a day,orally for 7-10 days and the controlled group treated with levo- floxaction in 200mg twice a day for 7-10 days.Result:The effective rate of the moxifloxaction group(93.9%)was high- er than that of the levofloxaction group(71.8%),but not significantly.The recovery rate of the moxifloxaction group (71.8%)was significantly higher than that of the levofloxaction group(46.9%);the days of recovery of clinical symptoms were not significantly different in the two groups.There was no significant difference between the two groups in the bacterial eradication rate.Conclusion:Moxifloxaction is effective and safe in the treatment of the lower respiratory tract inflection.
查看全文  查看/发表评论  下载PDF阅读器
关闭